Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03153982
Title Ruxolitinib in Operable Head and Neck Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications

head and neck squamous cell carcinoma

Therapies

Ruxolitinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.